Alalwan AA, Friedman J, Park H, Segal R, Brumback BA, Hartzema AG
Pasquale Del Vecchio for bibliometric and data management analysis
In the Chengdu study, 46% of participants reported injection site reactions, including localized itching and subcutaneous nodules
Contraindicated in patients with a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia Syndromes (MEN 2) Consult your healthcare provider if you have a history of pancreatitis, as the medication may increase risk Serious side effects may involve hypoglycemia, kidney issues, or allergic reactions 1,5 Not suitable for individuals with type 1 diabetes or diabetic ketoacidosis Medication interactions may occur with those on insulin, oral diabetes medications, oral contraceptives, and blood thinners
It is important to note that widespread views on neuroglia as a latent toxic cells, as dormant killers, which, when triggered, eat up healthy nervous tissue, are incorrect